how long have glp-1 drugs been around Glucagon-like peptide-1 receptor: mechanisms and advances in therapy GLP-1s were first approved in

In 2025 we saw label expansions for semaglutide and tirzepatide, underscoring a trend toward whole-body health

With the participation of researchers from the Paul Langerhans Institute Dresden (PLID), partner at the German Center for Diabetes Research, a GLP-1 receptor agonist in the form of tablets could for the first time be compared with the most common second-line therapy of T2D, a DPP-IV inhibitor

Learn how standard titration and microdosing compare and why a licensed provider should guide your dosing plan.

This product does not contain synthetic GLP-1 and is not a GLP-1 agonist drug

Start your weight-loss journey for the last time.

Learn what GLP-1 medications are, how they work, and which conditions they are used to treat.